Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

Share Price Information for Caspian Sunrise (CASP)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £49.48m
CASP Live PriceLast checked at - London Stock Exchange

Intraday Caspian Sunrise Share Chart

Schedule 1 - Roxi Petroleum

13 Feb 2008 16:17

AIM13 February 2008 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") COMPANY NAME:Roxi Petroleum plc COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :11 Gough SquareLondonEC4A 3DE COUNTRY OF INCORPORATION:England and Wales COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:www.roxipetroleum.com COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITSINVESTING STRATEGY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BESTATED:The Company's strategy is to build a diversified portfolio of oil and gas assets in Central Asia, initiallyKazakhstan. Following Admission the Company will have interests in, and operational control over five contractareas in Kazakhstan. Admission is sought as a result of a reverse takeover under AIM Rule 14 as a result of an acquisition of 59% ofthe issued share capital of Eragon Petroleum plc. DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. whereknown, number and type of shares, nominal value and issue price to which it seeks admission and the number andtype to be held as treasury shares): Number of shares: 320,130,567 Type: ordinary shares Nominal value: 10p each Issue price: 65 pence being the price per share of the Consideration Shares to be issued to the vendors of Eragon Petroleum plc CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:No Capital to be raised on Admission Anticipated Market capitalisation on Admission : Β£208.1 million based on the share price of 65p per share of theConsideration Shares PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:46% DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THECOMPANY) ARE OR WILL BE ADMITTED OR TRADED:N/A FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is knownor including any other name by which each is known):Clive Nathan Carver, (Non-Executive Chairman)Jean Joseph Louis Robert (Rob) Schoonbrood, (Chief Executive Officer)David Robert Barker, (Chief Operating Officer)Duncan McDougall (Technical Director)Kuat Rafikuly Oraziman, (Non-Executive Director) FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFOREAND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which eachis known): BEFORE ADMISSION Credit Agricole Cheuvreux International Limited 3439 Acct 10.73% Credit Suisse Securities (Europe) Limited Principal Acct 8.40% HSBC Global Custody Nominee (UK) Limited 813259 Acct 7.29% Goldman Sachs Securities (Nominees) Limited ILSEG Acct 6.72% Deutsche Bank Aktiengesellschaft London Prop0001 Acct 6.15% Pershing Keen Nominees Limited TYCLT Acct 5.42% ABN Amro Bank NV Branch Hub Acct 4.72% Chase Nominee Limited 3.56% Chocolate Chip Participation Corporation 3.49% Pinegrove Equities Inc. 3.13% Chase Nominee Limited CMBL ACCT 3.09% AFTER ADMISSION Baverstock GmbH 45.29% Credit Agricole Cheuvreux International Limited 3439 Acct 5.64% Credit Suisse Securities (Europe) Limited Principal Acct 4.41% HSBC Global Custody Nominee (UK) Limited 813259 Acct 3.83% Goldman Sachs Securities (Nominees) Limited ILSEG Acct 3.53% Deutsche Bank Aktiengesellschaft London Prop0001 Acct 3.23% NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:Mr David Slater. Details provided in paragraph 12.14 of Part VI of the Admission Document. (i) ANTICIPATED ACCOUNTING REFERENCE DATE (ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19: (i) Anticipated Accounting reference date is 31 December (ii) 30 June 2007 (iii) 31 December 2007 annual accounts (publish by 30 June 2008 latest), 30 June 2008 interims(notification by 30 September 2008 latest), 31 December 2008 annual accounts (publish by 30 June 2009 latest) EXPECTED ADMISSION DATE:3 March 2008NAME AND ADDRESS OF NOMINATED ADVISER:WH Ireland Limited 24 Martin Lane London EC4R 0DRNAME AND ADDRESS OF BROKER:WH Ireland Limited 24 Martin Lane London EC4R 0DROTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSIONDOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THEADMISSION OF ITS SECURITIES:The admission document will contain full details about the Company and the admission of its common shares to AIM.The admission document will be available at the offices of WH Ireland Limited, 24 Martin Lane, London EC4R 0DRDATE OF NOTIFICATION:13 February 2008NEW/ UPDATE:New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Sep 20247:00 amRNSProposed disposal of MJF & South Yelemes
2nd Sep 20242:27 pmRNSGeneral Update
18th Jul 20247:00 amRNSUpdate on Proposed Sale
15th Jul 20248:50 amRNSRestoration - Caspian Sunrise plc
15th Jul 20247:39 amRNSPosting of Accounts
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
15th Jul 20247:00 amRNSAnnual Report for the Year Ended 31 December 2023
12th Jul 202412:38 pmRNSGeneral Update
8th Jul 20241:43 pmRNSUpdate
2nd Jul 20247:00 amRNSOperational Update
1st Jul 20247:30 amRNSSuspension - Caspian Sunrise plc
27th Jun 20243:42 pmRNSResult of AGM
27th Jun 20247:01 amRNSGeneral Update / AGM statement
27th Jun 20247:00 amRNSPreliminary Unaudited Results year end 31 Dec 2023
14th Jun 202410:42 amRNSReserve update
3rd Jun 20249:21 amRNS2024 AGM
14th May 20247:00 amRNSProposed Sale of the BNG shallow structures
25th Apr 20241:08 pmRNSGeneral Meeting Results
24th Apr 20247:00 amRNSIssue of Equity and Option Awards
8th Apr 20247:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
25th Mar 20247:00 amRNSStrategic & Operational Update
16th Feb 20247:00 amRNSBNG Operational update
21st Dec 20237:00 amRNSOperational Update
31st Oct 20237:00 amRNSOperational update
25th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
31st Jul 202312:49 pmRNSGM results
31st Jul 20237:00 amRNSGeneral Meeting & BNG and Caspian Explorer updates
11th Jul 202312:50 pmRNSHolding(s) in Company
10th Jul 20237:00 amRNSBoard change, Posting of the 2022 Results
7th Jul 20237:30 amRNSRestoration- Caspian Sunrise plc
7th Jul 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
3rd Jul 20237:30 amRNSSuspension - Caspian Sunrise plc
30th Jun 20233:51 pmRNSAGM results
30th Jun 20237:00 amRNSAGM Statement
12th Jun 20237:00 amRNS50% Sale of Caspian Explorer & Operational Update
1st Jun 20239:26 amRNSAGM and 2022 Accounts update
7th Mar 20237:00 amRNSCaspian Explorer contract signed & Dividend update
20th Feb 20237:00 amRNSCaspian Explorer update & Dividend update
30th Jan 20237:00 amRNSDeep well update
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202311:05 amRNSSecond Price Monitoring Extn
16th Jan 202311:00 amRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSTender Update
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.